Article Text

PDF
Original article
The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial
  1. Pascal Meier1,
  2. Alexandra J Lansky2,
  3. Martin Fahy3,
  4. Ke Xu3,
  5. Harvey D White4,
  6. Michel E Bertrand5,
  7. Roxana Mehran3,
  8. Gregg W Stone3
  1. 1University College London, The Heart Hospital, London, UK
  2. 2Yale Cardiovascular Research Group, Yale University School of Medicine, New Haven, Connecticut, USA
  3. 3Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
  4. 4Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
  5. 5Hopital Cardiologique, Lille, France
  1. Correspondence to Dr Alexandra J Lansky Yale Cardiovascular Research Group, Yale University School of Medicine, 1 Church Street, Suite 330, New Haven, CT 06510, USA; alexandra.lansky{at}yale.edu

Abstract

Objective We sought to assess the prognostic role of collaterals in a large population of patients presenting with an acute coronary syndrome (ACS).

Methods The coronary collateral circulation was assessed by an independent angiographic core laboratory using the Rentrop Score in patients enrolled in the randomised Acute Catheterization and Urgent Intervention Triage Strategy trial.

Results The cohort comprised 5412 patients with moderate to high risk ACS. A total of 858 patients (16.0%) had visible collaterals while 4554 patients (84.0%) had no collaterals. After multivariable adjustment, there were no differences in clinical outcomes at 1 year between the groups, including major adverse cardiac events (MACE) (HR 0.94 (95% CI 0.76 to 1.16), p=0.55), mortality (HR 1.03 (0.65 to 1.62), p=0.91), myocardial infarction (MI) (HR 1.07 (0.83 to 1.38), p=0.60) and unplanned target vessel revascularisation (TVR) (HR 0.95 (0.71 to 1.28), p=0.75). Similarly, in the subgroup of patients undergoing percutaneous coronary intervention (PCI), the adjusted HR for major adverse cardiac events was 1.1 (0.76 to 1.61), p=0.595; 0.81 (0.10 to 6.44), p=0.999 for mortality; and 0.86 (0.54 to 1.35), p=0.564 for MI. The risk of unplanned TVR was increased (HR 2.74 (1.48 to 5.10), p=0.004).

Conclusions In contrast to other studies, this large core laboratory-based analysis does not confirm a beneficial role of visible coronary collateral vessels on clinical outcomes in patients with ACS; the presence of collaterals was even associated with increased mortality in the unadjusted analysis. Collaterals were associated with a higher risk of TVR in patients undergoing PCI, a finding that may not have been fully corrected given confounders and clinical differences between the groups.

Trial registration ClinicalTrials.gov Identifier: NCT00093158.

  • INTERVENTIONAL CARDIOLOGY

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles